MVG Insights
Providing clinical development insight to the biotechnology and pharmaceutical industries
Featured News:
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions...
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions...
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is...
With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite...
We are Hiring – Open Contractor Positions at MVG Consulting
Looking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!
COVID-19 Heightens Call for Diversity within Biopharma
COVID-19, and its disproportionate effect on minority populations highlighted the need for increased diversity in clinical trials in order to adequately treat every patient population. The biopharma industry has resisted diversification in the past because its...
Decentralized Clinical Trials: Here Comes the Future
Once a seemingly far-fetched endeavor, decentralized clinical trials are gaining favor in the wake of COVID-19. It has become clear that the time for entirely in-person clinical trials has passed, paving the way for a new, technologically integrated approach. This...
MVG Teams up with World Computer Exchange
At the end of this uniquely challenging year, MVG Consulting would like to take a moment to thank those who have had an indelible impact throughout this difficult time. To the frontline workers, who have worked tirelessly, adapting to every changing circumstance this...
How Covid-19 could drive a shift toward decentralized clinical trials
Heading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward...
Virtual Pharma: How Technology is Paving the Way for Increased Innovation
Technological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased...
MVG News:
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is...
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions...
The Impact of the Immune System: How studying the immune reactions to COVID-19 will help scientists to develop more effective vaccines
As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions...
Novel Retinal Disease Treatments? Iveric Bio Begins the Search for Potential Gene Therapies
To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is...
With Demands for Additional Data, the FDA Pauses Merck’s MK-7110 Summer Rollout
When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite...
We are Hiring – Open Contractor Positions at MVG Consulting
Looking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!
COVID-19 Heightens Call for Diversity within Biopharma
COVID-19, and its disproportionate effect on minority populations highlighted the need for increased diversity in clinical trials in order to adequately treat every patient population. The biopharma industry has resisted diversification in the past because its...
Decentralized Clinical Trials: Here Comes the Future
Once a seemingly far-fetched endeavor, decentralized clinical trials are gaining favor in the wake of COVID-19. It has become clear that the time for entirely in-person clinical trials has passed, paving the way for a new, technologically integrated approach. This...
MVG Teams up with World Computer Exchange
At the end of this uniquely challenging year, MVG Consulting would like to take a moment to thank those who have had an indelible impact throughout this difficult time. To the frontline workers, who have worked tirelessly, adapting to every changing circumstance this...
How Covid-19 could drive a shift toward decentralized clinical trials
Heading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward...
Virtual Pharma: How Technology is Paving the Way for Increased Innovation
Technological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased...
Rapid Scientific Innovation Begs the Question of Integrity
The speed with which COVID-19 vaccines are being developed leaves many uncertain about the safety and effectiveness of a potential vaccine. The global conference hosted by Harvard and MIT confronts this uncertainty and probes the question of how to evaluate and...